Detalhe da pesquisa
1.
Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals.
AIDS
; 20(3): 405-13, 2006 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16439874
2.
Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.
AIDS
; 19(3): 279-86, 2005 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15718838
3.
Use of well-defined HIV-derived epitopes to evaluate CD4(+) and CD8(+) T cell responses in patients with chronic HIV-1 infection treated with HAART.
AIDS Res Hum Retroviruses
; 20(8): 827-35, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15320987
4.
Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.
J Virol
; 76(6): 2899-911, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11861857
5.
Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response.
J Virol
; 76(1): 127-35, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11739678
6.
Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized.
J Virol
; 77(20): 11220-31, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14512570
7.
Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.
Int J Cancer
; 98(2): 221-7, 2002 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-11857412
8.
HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.
J Immunol
; 169(12): 6928-34, 2002 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12471126